Insider Transactions and Holdings
-
Entity Type
-
Company
-
Role
-
10%+ Owner
-
Stock Symbol
-
XLO on Nasdaq
There are no Buy or Sell transactions made by SV7 Impact Medicine Fund LP since 9/17/2023
Holdings reported by SV7 Impact Medicine Fund LP for Xilio Therapeutics, Inc.
| Class |
Num Shares |
Value |
Price $ |
Transaction Date |
Ownership |
Underlying Class |
Underlying Amount |
| Common Stock |
1.61M |
$1.34M |
$0.83 |
Oct 26, 2021 |
Direct |
|
|
| Common Stock |
1.61M |
$1.34M |
$0.83 |
Oct 26, 2021 |
Indirect |
|
|
| Series B Convertible Preferred Stock |
0 |
|
|
Oct 26, 2021 |
Direct |
Common Stock |
|
| Series B Convertible Preferred Stock |
0 |
|
|
Oct 26, 2021 |
Indirect |
Common Stock |
|
| Series C Convertible Preferred Stock |
0 |
|
|
Oct 26, 2021 |
Direct |
Common Stock |
|
| Series C Convertible Preferred Stock |
0 |
|
|
Oct 26, 2021 |
Indirect |
Common Stock |
|
Transactions reported by SV7 Impact Medicine Fund LP for Xilio Therapeutics, Inc.
| Sym |
Class |
Transaction |
% |
Value $ |
* Price $ |
Shares |
Shares After |
Date |
Ownership |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.